Kane Biotech (KNE.V)
- Last 24‑hour performance: flat 0 %
- Current price: CAD 0.03
- Shares outstanding: 205 million
- Market capitalization: CAD 6.2 million
- Volume traded in last 24 hours: approximately CAD 3 k
- Price trend since last month end: flat 0 %
- 200‑day simple moving average: CAD 0.03
- 52‑week high: CAD 0.05 (22 January 2026)
- 52‑week low: CAD 0.02 (8 September 2026)
Comparative performance of related stocks (last 24 hours)
| Stock | Ticker | 24‑hour change | Current price | Market capitalization |
|---|---|---|---|---|
| Tsodilo | TSD.V | flat 0 % | CAD 0.11 | CAD 7.3 million |
| Sorrento | SRS.CN | down 4.17 % | CAD 0.12 | CAD 7.4 million |
| Zimtu Capital | ZC.V | flat 0 % | CAD 0.43 | CAD 7.4 million |
| P/E ratio: 0.38 | ||||
| Asiatel Outsourcing | ATOI.V | down 3.45 % | CAD 0.14 | CAD 7.2 million |
| Tesoro Minerals | TES.V | up 14.29 % | CAD 0.13 | CAD 7.2 million |
Company overview
Kane Biotech Inc. is headquartered in Winnipeg, Canada. The company focuses on developing technologies to prevent and disperse bacterial biofilms. Its research targets the formation processes of biofilms, aiming to improve methods for prevention and destruction. Success in this area could impact a range of medical and industrial applications.
